Recent updates in COVID-19 with emphasis on inhalation therapeutics: Nanostructured and targeting systems
The current world health threat posed by the novel coronavirus disease of 2019 (COVID-19) calls for the urgent development of effective therapeutic options. COVID-19 needs daunting routes such as nano-antivirals. Hence, the role of nanotechnology is very critical in combating this nano-enemy “virus.” Although substantial resources are under ongoing attention for prevention and care, we would like to start sharing with readers our vision of the role of inhaled nanomaterials and targeting systems that can play an important role in the fight against the COVID-19.
Recent updates in COVID-19.
Pathogenesis and clinical presentation of COVID-19.
Corona virus and lungs.
Nanomaterials and COVID-19.
Inhalation therapeutics for COVID-19.
In this review, we underline the genomic structure of COVID-19, recent modes of virus transmission with measures to control the infection, pathogenesis, clinical presentation of SARS-CoV-2, and how much the virus affects the lung. Additionally, the recent therapeutic approaches for managing COVID-19 with emphasis on the value of nanomaterial-based technical approaches are discussed in this review.
This review also focuses on the safe and efficient delivery of useable targeted therapies using designed nanocarriers. Moreover, the effectiveness and availability of active targeting of certain specific receptors expressed on the coronavirus surfaces via tailored ligand nanoparticles are manipulated. It was also highlighted in this review the role of inhaled medicines including antivirals and repurposed drugs for fighting the associated lung disorders and efficiency of developed vaccines. Moreover, the inhalation delivery safety techniques were also highlighted.
Article information: Ahmed A.H. Abdellatif, Hesham M. Tawfeek, Ahmed Abdelfattah, Gaber El-Saber Batiha, Helal F. Hetta. Recent updates in COVID-19 with emphasis on inhalation therapeutics: Nanostructured and targeting systems,
Journal of Drug Delivery Science and Technology, Volume 63, 2021. https://doi.org/10.1016/j.jddst.2021.102435.